Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Investment AB Latour (publ) issues bond loans

Today Investment AB Latour issued two bond loans of in total SEK 1,000 m, within the aggregate nominal amount of the existing MTN program. The first bond loan amounts to SEK 700 m with a tenor of 5 years and carries a floating interest rate of three months STIBOR + a margin of 0.85 per cent annually. The second bond loan amounts to SEK 300 m with a tenor of 5 years and carries a fixed interest rate of 3.788 per cent annually. Handelsbanken, SEB and Nordea have arranged the issuance. Göteborg, May 30, 2024 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO For further

The Wait is Over: The LEGO Group and Fingersoft Officially Release LEGO® Hill Climb Adventures

The new mobile game, LEGO® Hill Climb Adventures, is now globally available to play via Google Play and Apple App Store.The LEGO Group and Fingersoft have today announced the global release of LEGO® Hill Climb Adventures. LEGO® Hill Climb Adventures is a new take on Fingersoft’s popular Hill Climb Racing games, combining the evergreen gameplay and world of Hill Climb Racing with the creative fun of LEGO play.    In the single-player exploration game, the player embarks on a grand adventure, braving the hills in 3D. With a variety of Hill Climb Racing and LEGO brick vehicles and

Nel ASA: Receives purchase order from Alperia Greenpower SRL for hydrogen fueling equipment in Italy

(Oslo, 30 May 2024) A subsidiary of Cavendish Hydrogen ASA, itself a subsidiary of Nel ASA (Nel, OSE: NEL) has received a purchase order from Alperia Greenpower SRL for hydrogen fueling equipment for one site to be used for light- and heavy-duty fuel cell electric vehicles in Bruneck, South Tyrol, Italy.“We are pleased to be chosen by Alperia to be the supplier of their first hydrogen fueling station. It will also be Nel’s first H2Station™ installation in Italy, and we are looking forward to deliver and demonstrate our performance and capabilities in this lighthouse project”, says Robert

Balloon bonanza at Esrange: Record breaking launches in northern Sweden

In close collaboration with strategic partners like NASA and CNES, Swedish Space Corporation (SSC) is launching a record amount of eight stratospheric balloons this summer. The largest one measures three times the size of the Globe (Avicii Arena) in Stockholm, and will fly high above the Atlantic to a safe landing in Canada. These are hectic times at the Esrange Space Center outside Kiruna in northern Sweden. A total of eight stratospheric balloons – five transatlantic, two stationary and one student balloon – will be launched from Esrange within a matter of weeks. A record in both

Clas Ohlson expands in Drammen with a new store

This morning, Clas Ohlson opened a new store in Drammen, south of Oslo. Clas Ohlson now has three stores in Drammen."It feels incredibly exciting to continue growing in Drammen and open a third store. The new store is very easily accessible and allows us to now cover the entire Drammen municipality," says Rune Johansen, Country Operations Manager. The new store is located in CC Drammen shopping centre in eastern Drammen and has a sales area of 860 square meters. The store offers the entire Clas Ohlson range, including storage and cleaning products, technology products, and products for

Pak Logistik Intressenter AB holds more than 30 per cent of the shares and votes in Jetpak

This press release is not an offer to acquire shares. This press release is made in accordance with the Swedish Stock Market Self-Regulation Committee’s Takeover rules for certain trading platforms. Pak Logistik Intressenter AB, reg. no. 559469-9505 (“Pak Logistik Intressenter”), a company that is wholly owned by Paradeigma Partners AB, reg. no. 559122-5668 (“Paradeigma”), has by way of exercising a right to repurchase previously sold shares[1] acquired 527,042 shares in Jetpak Top Holding AB (publ) (“Jetpak”). Through the acquisition, Pak Logistik Intressenter and Paradeigma has reached

Announcement from the Annual General Meeting in Bawat Water Technologies AB on 30 May 2024

Bawat Water Technologies AB held its Annual General Meeting on 30 May 2024. The main resolutions passed at the meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the company’s website.Adoption of income statements and balance sheets The meeting resolved to adopt the income statement and the balance sheet, as well as the consolidated income statement and the consolidated balance sheet for the financial year 2023.Allocation

Kongsberg Automotive – Minutes of the Annual General Meeting

Oslo, May 30, 2024: The Annual General Meeting of Kongsberg Automotive ASA was held today, May 30, 2024. The Minutes of the Annual General Meeting is attached and also available on the company's website www.kongsbergautomotive.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.  About Kongsberg Automotive ASAKongsberg Automotive provides cutting-edge technology to the global vehicle industry. We drive the global transition to sustainable mobility by putting engineering, sustainability, and innovation into

Where & how to do Midsummer in Sweden - the ultimate Swedish experience

Did you know the Christian tradition of celebrating St. John the Baptist coincides with the summer solstice? In Northern Europe, this date is still marked with bonfires and festivities. Since the late Middle Ages, Swedes have celebrated by raising and dancing around a Midsummer pole. Decorating it with flowers and greenery, a practice known as 'maja', gives the pole its other name: the maypole. Photo: Anna Hållams/imagebank.sweden.se (Download ) Midsummer’s Eve is one of Sweden’s most cherished

NextCell publishes prospectus in connection with the rights issue of units of approximately SEK 40.1 million

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG, BELARUS, RUSSIA OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLISHING OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW. SEE SECTION ”IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. NextCell Pharma AB (publ) (”NextCell” or the “Company”) has prepared an EU

ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant

ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant The Swedish Energy Agency changes its decision from November 29, 2012, so that support in the form of an advance with repayment obligation to ChromoGenics AB (Conditional Loan) is now converted to a grant. On November 29, 2012, ChromoGenics AB was granted support to carry out a project by the Energy Agency. The support was provided in the form of an advance with a repayment obligation (Conditional Loan), which is a loan where the repayment conditions depend on the project's outcome. The Swedish Energy

BioStock: BioInvent to present promising clinical data at ASCO and EHA

In the coming weeks, BioInvent is set to present three significant data sets at the American Society for Clinical Oncology’s (ASCO) annual congress and the European Hematology Association’s (EHA) annual meeting. At ASCO, BioInvent will showcase advancements with BI-1808 monotherapy and BI-1206 in combination with Keytruda. At EHA, promising data on BI-2106 will be presented to the expert community.Read the article at biostock.se: https://www.biostock.se/en/2024/05/bioinvent-to-present-promising-clinical-data-at-asco-and-eha/ This is a press release from BioStock - Connecting

Lundbergs Interim Report January - March 2024

· On March 31, 2024, net asset value after deferred tax amounted to SEK 142.8 billion (SEK 576 per share), compared with SEK 135.1 billion (SEK 545 per share) on December 31, 2023. The corresponding values on May 28, 2024 were SEK 141.2 billion (SEK 569 per share).  · Consolidated net sales amounted to SEK 7,982 m. (8,062).  · Profit after financial items amounted to SEK 4,863 m. (3,883) where earnings from participations in associated companies amounted toSEK 3,352 m. (2,646). Profit after financial items excluding unrealized changes in value amounted to SEK 5,706 m. (5,385).

5,000 patients treated with OssDsign Catalyst® in the U.S.

Uppsala, May 30, 2024. Today, OssDsign AB (publ.) announces that the company continues its successful penetration of the U.S. orthobiologics market. To date, 5,000 patients have been treated with the innovative nanosynthetic bone graft OssDsign Catalyst.The continuous and rapid increase in treated patients is a strong testament to how well OssDsign Catalyst has been received in the U.S. market since its launch in August 2021.   “With 5,000 patients treated, the use of OssDsign Catalyst is not just growing, it's accelerating. This is a significant leap from the earlier announcements of

Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2024

In light of the incentive program adopted by the annual general meeting of Medivir AB (publ) (“Medivir”) on 7 May 2024 (“LTIP 2024”), it is today announced that the board of directors of Medivir has resolved on (i) a share issue of 1,700,000 shares of series C, (ii) repurchase of the 1,700,000 shares of series C, (iii) reclassification of 114,587 shares of series C into ordinary shares and (iv) partial execution of the annual general meeting’s resolution on transfer of own ordinary shares by transferring 126,000 own ordinary shares to participants in LTIP 2024.Aktieinvest FK AB will

poLight ASA - Invitation to presentation of Q1 2024 results

poLight ASA (OSE: PLT) will release its first quarter 2024 results on Tuesday 4 June 2024 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST at Continental, Stortingsgaten 24/26, in Oslo, Norway which is open to the public. The presentation and supporting material will be in English. The presentation can also be followed through live webcast. Please join the Q1 2024 results webcast by https://channel.

Grocery retailer Alphamega orders 37 MSEK of electronic shelf labels

Pricer’s partner StrongPoint has signed an agreement with Alphamega, the largest grocery retailer in Cyprus, to install electronic shelf labels in all its stores. The value of the contract is approximately 37 MSEK and the rollout is expected to begin in 2024 and be completed by 2026.“We are excited that our solution will support Alphamega in its digitalization journey. The adoption of our cloud-based platform Pricer Plaza represents a significant leap forward and empowers this leading retailer with centralized control and management of pricing, product information, and promotions across all

DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING

held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”)Thursday, 30 May 2024 at 09:00 am (CET) On 30 May 2024 at 09:00 am (CET), the annual general meeting of 2024 was held in the Company at the Company’s address, Rugvænget 5, 6823 Ansager, Denmark. The agenda for the annual general meeting was as follows: 6. `. 1. 1. 1. 1. 1. The chairman’s report on the activities of the Company in the past financial year 2. Adoption of the annual report for 2023 3. Covering of loss pursuant to the adopted

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Södertälje, Sweden, & San Francisco, USA and Kyoto, Japan, 30 May 2024 – Anocca AB  (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8 αβT-cell therapies (iPS-T), today announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies (TCR-iPS-T)

Collegiate style for the wrist

Preppy in primary colors: NOMOS Tangente 38 date Love in red, white, and blue.GLASHÜTTE, MAY 24, 2024. Whether worn with cashmere, check, or a pleated skirt and tennis socks—this watch combines modern design with classic style and always remains straightforward, flattering, and perfectly proportioned. An elegant answer to the question of whether there is a watch that goes with everything, and a wonderful way to elevate more casual, everyday outfits. Key Facts Tangente 38 date Love Colors:red, white, blue(brick red, cream, pool blue, orange) Target group:sporty, neat,

Dive into the blue with Super Sardine

With this watch on your wrist, you will always make a splash—even on dry land. A must-have for all those who want to add a maritime flair to their look.GLASHÜTTE, MAY 30, 2024. Inspired by the many shades of the sea, Tangente Super Sardine brings a nautical touch to everyday life. This NOMOS watch with a date display represents perseverance, character, confidence, and common sense. Whether worn while on vacation by the coast or while planning the next trip at home, with smart casual or more formal attire—Tangente Super Sardine guarantees elegance and buoyancy in any situation. Key Facts

ODI Pharma AB: Publication of interim report Q3 2023/2024

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 - March 2024. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Third quarter (2024-01-01 – 2024-03-31)The Group's net sales amounted to SEK 13,856,539 (10,801).The Group's profit after financial items amounted to SEK 1,389,713 (-942,440).Result per share amounted to SEK 0,09 (-0.06).*  Nine months (2023-07-01 – 2024-03-31)The Group’s net sales amounted to SEK 14,777,194 (112,

There are no items matching the current filter
There are no more items matching the current filter
Back to top